丹曲林钠与地西泮治疗痉挛的比较。
Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
作者信息
Schmidt R T, Lee R H, Spehlmann R
出版信息
J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):350-6. doi: 10.1136/jnnp.39.4.350.
Abstract
The effects of dantrolene sodium and diazepam were compared in a double crossover study of 42 patients with spasticity due to stable multiple sclerosis. Both drugs reduced the findings of spasticity, clonus, and hyperreflexia, and the complaints of muscle stiffness and cramping. Each drug had different side effects which suggest indications and contraindications for its use in spastic patients.
摘要
在一项针对42例因稳定型多发性硬化症导致痉挛的患者的双交叉研究中，比较了丹曲林钠和地西泮的效果。两种药物均减轻了痉挛、阵挛和反射亢进的表现，以及肌肉僵硬和抽筋的主诉。每种药物都有不同的副作用，这提示了其在痉挛患者中使用的适应证和禁忌证。
相似文献
1
Comparison of dantrolene sodium and diazepam in the treatment of spasticity.丹曲林钠与地西泮治疗痉挛的比较。
J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):350-6. doi: 10.1136/jnnp.39.4.350.
2
Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
Trans Am Neurol Assoc. 1975;100:235-7.
3
A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
Paraplegia. 1974 Nov;12(3):170-4. doi: 10.1038/sc.1974.27.
4
The effect of dantrolene sodium on spasticity in multiple sclerosis.丹曲林钠对多发性硬化症痉挛的影响。
Neurology. 1973 Dec;23(12):1313-5. doi: 10.1212/wnl.23.12.1313.
5
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.丹曲林钠：其药理学特性及在痉挛治疗中疗效的综述
Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002.
6
[Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].丹曲林钠（硝苯呋海因）治疗多发性硬化症的临床研究（作者译）
Acta Neurol Belg. 1978 May-Jun;78(3):141-7.
7
Dantrolene sodium: long-term effects in severe spasticity.
Arch Phys Med Rehabil. 1973 Jul;54(7):311-5.
8
Dantrolene sodium for treatment of spasticity.
Med Lett Drugs Ther. 1974 Jul 19;16(15):61-2.
9
Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.丹曲林钠治疗慢性脊髓疾病中的痉挛状态
Practitioner. 1978 Jul;221(1321):123-7.
10
Medical treatment for spasticity in children with cerebral palsy.脑瘫患儿痉挛状态的医学治疗
Childs Brain. 1976;2(5):304-8. doi: 10.1159/000119626.
引用本文的文献
1
Pain Management in Multiple Sclerosis: a Review of Available Treatment Options.多发性硬化症的疼痛管理：现有治疗选择综述
Curr Treat Options Neurol. 2019 Nov 27;21(12):62. doi: 10.1007/s11940-019-0601-2.
2
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.多发性硬化症的对症治疗：一种临床实践中多模式方法的综述。
Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.
3
Motor Restoration and Spasticity Management after Stroke.中风后的运动功能恢复与痉挛管理
Curr Treat Options Neurol. 2002 Nov;4(6):427-433. doi: 10.1007/s11940-002-0010-8.
4
Evidence basis for treatment of spasticity.痉挛治疗的证据基础。
Curr Neurol Neurosci Rep. 2001 Nov;1(6):501-6. doi: 10.1007/s11910-001-0051-5.
5
Anti-spasticity agents for multiple sclerosis.用于治疗多发性硬化症的抗痉挛药物。
Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332.
6
Pharmacological interventions for spasticity following spinal cord injury.脊髓损伤后痉挛的药物干预措施。
Cochrane Database Syst Rev. 2000;2000(2):CD001131. doi: 10.1002/14651858.CD001131.
7
Drugs used to treat spasticity.用于治疗痉挛的药物。
Drugs. 2000 Mar;59(3):487-95. doi: 10.2165/00003495-200059030-00006.
8
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.丹曲林。对其药效学、药代动力学特性以及在恶性高热、抗精神病药物恶性综合征中的治疗用途的综述，并更新其在肌肉痉挛中的应用。
Drugs. 1986 Aug;32(2):130-68. doi: 10.2165/00003495-198632020-00003.
9
Relationship between plasma concentration and effect of dantrolene sodium in man.
Eur J Clin Pharmacol. 1979 Sep;16(3):203-9. doi: 10.1007/BF00562062.
10
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.丹曲林钠：其药理学特性及在痉挛治疗中疗效的综述
Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002.
本文引用的文献
1
Efficacy of dantrolene sodium in the treatment of spasticity.丹曲林钠治疗痉挛的疗效。
Dis Nerv Syst. 1974 Sep;35(9):427-31.
2
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL.定量临床神经学检测。一、一组旨在部分评估多发性硬化症患者神经功能的检测方法的研究及其在一项治疗试验中的应用。
Ann N Y Acad Sci. 1965 Mar 31;122:480-505. doi: 10.1111/j.1749-6632.1965.tb20231.x.
3
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.关于多发性硬化症残疾评估的进一步说明及量表修改
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
4
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. II. SOME STATISTICAL CONSIDERATIONS OF A BATTERY OF TESTS.定量临床神经学检测。II. 一组检测的一些统计学考量。
J Chronic Dis. 1965 Mar;18:303-11. doi: 10.1016/0021-9681(65)90157-8.
5
An assessment of the reliability of three methods used in evaluating the status of multiple sclerosis patients.对用于评估多发性硬化症患者病情的三种方法的可靠性评估。
J Chronic Dis. 1969 Apr;21(11):803-14. doi: 10.1016/0021-9681(69)90026-5.
6
Spasticity and its amelioration.
Mod Trends Neurol. 1970;5(0):41-59.
7
Oral diazepam in the treatment of spasticity in paraplegia a double-blind trial and subsequent impressions.口服地西泮治疗截瘫痉挛的双盲试验及后续观察
Scott Med J. 1966 Feb;11(2):46-51. doi: 10.1177/003693306601100202.
8
Long-term follow-up on the use of diazepam in the treatment of spasticity.地西泮治疗痉挛的长期随访
Am J Phys Med. 1968 Jun;47(3):143-9.
9
Drugs in the management of spasticity.用于治疗痉挛状态的药物。
Dev Med Child Neurol. 1971 Jun;13(3):386-8. doi: 10.1111/j.1469-8749.1971.tb03278.x.
10
A double blind, cross-over trial of Valium in the treatment of spasticity.一项关于安定治疗痉挛的双盲交叉试验。
Paraplegia. 1972 May;10(1):19-22. doi: 10.1038/sc.1972.4.
Zotero 插件